XML 75 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (Details Narrative 1) (USD $)
 12 Months Ended 1 Months Ended 0 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 1 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Nov. 13, 2012
Mr. Finizio
Nov. 13, 2012
Mr. Milligan
Nov. 13, 2012
Reich Family Limited LP
May 31, 2013
Sancilio & Company Warrants
Jun. 30, 2013
Sancilio & Company Warrants 1st Installments
May 11, 2013
Sancilio & Company Warrants 1st Installments
Jun. 30, 2013
Sancilio & Company Warrants 2nd Installments
Dec. 31, 2013
Sancilio & Company Warrants 2nd Installments
Dec. 31, 2013
Sancilio & Company Warrants 3rd Installments
Feb. 29, 2012
Modification Warrants
Mar. 31, 2012
Warrants Issued to Unaffiliated Individuals
Number
May 31, 2012
Warrants Issued to Unaffiliated Entity
Dec. 31, 2013
Warrants Issued to Unaffiliated Entity
Dec. 31, 2012
Warrants Issued to Unaffiliated Entity
Jun. 19, 2012
June 2012 Notes/Warrants
Dec. 31, 2012
June 2012 Notes/Warrants
Jun. 19, 2012
June 2012 Notes/Warrants 1st Issue
Jun. 19, 2012
June 2012 Notes/Warrants 2nd Issue
Jun. 30, 2012
Warrants Issued to Unaffiliated Individuals
Number
Dec. 31, 2011
Warrants Issued to Unrelated Individual for Consulting Services
Dec. 31, 2011
Warrants Issued to Unrelated Individual for Consulting Services
Oct. 31, 2011
Warrants Issued Officers
Dec. 31, 2013
Warrants Issued Officers
Dec. 31, 2012
Warrants Issued Officers
Dec. 31, 2011
Warrants Issued Officers
Dec. 31, 2011
Warrants Issued to Unrelated Entity for Consulting Services
Dec. 31, 2011
Warrants Issued to Unrelated Entity for Consulting Services
Dec. 31, 2011
Vested non forfeitable VitaMed Warrants
Mar. 31, 2011
Vested non forfeitable VitaMed Warrants
Dec. 31, 2013
Vested non forfeitable VitaMed Warrants
Number
Dec. 31, 2012
Vested non forfeitable VitaMed Warrants
Dec. 31, 2011
Vested non forfeitable VitaMed Warrants
Nov. 13, 2012
Vested non forfeitable VitaMed Warrants
Jan. 31, 2013
Multiple Advance Revolving Credit Note (Plato Warrant)
Dec. 31, 2013
Multiple Advance Revolving Credit Note (Plato Warrant)
Feb. 29, 2012
February 2012 Notes/ Warrants
Feb. 24, 2012
February 2012 Notes/ Warrants
Jun. 30, 2011
VitaMed Promissory Notes
Nov. 13, 2012
VitaMed Promissory Notes
Mar. 31, 2011
VitaMed Promissory Notes
Mar. 31, 2011
VitaMed Promissory Notes
Mr. Finizio
Mar. 31, 2011
VitaMed Promissory Notes
Mr. Milligan
Mar. 31, 2011
VitaMed Promissory Notes
Reich Family Limited LP
Dec. 31, 2013
Minimum
Dec. 31, 2013
Maximum
Dec. 31, 2013
Weighted Average
Warrants:                                                                                                  
Warrants outstanding $ 14,293,499                                                                                                
Weighted-average contractual remaining life 3 years 10 months 24 days                                                                                                
Exercise price of warrants (in dollars per share)             2.01           0.38   2.57         2.00 3.00       0.38       0.38 0.38 0.41 0.24     0.41   3.20   0.38   0.41           0.24 3.20 1.79
Unamortized costs of warrants 1,599,000                                                                                                
Number of shares purchased             850,000   283,333 283,333   283,334 3,314,700 31,000 1,300,000     7,000,000   6,000,000 1,000,000 1,500 500 500 600,000 7,158 36,284 36,284 184,211 184,211 200,000   93,969   200,000   1,250,000   5,685,300 3,314,700 613,718                
Expiration date of warrants                                                                         Jan. 31, 2019                        
Vesting date of warrants                 Jun. 30, 2013                                                       Oct. 31, 2013                        
Fair value of warrants               405,066   462,196     6,124,873   1,532,228     9,424,982         338 338 133,045       25,980 25,980 12,548       12,548   1,711,956   10,505,247   30,993                
Expected term               5 years   5 years     5 years 5 years 5 years     5 years       5 years 10 years   10 years       5 years   5 years   10 years       6 years   5 years   5 years                
Volatility rate               45.89%   45.84%     44.50% 44.81% 44.71%     44.64%       44.78% 51.83%   45.94%       41.04%   39.44%   47.89%       44.29%   44.50%                    
Risk free rate               45.89%   1.41%     89.00% 1.04% 0.74%     0.75%       0.72% 0.91%   2.23%       1.08%   1.56%   3.48%       0.88%   89.00%                    
Dividend yield               0.00%   0.00%     0.00% 0.00% 0.00%     0.00%       0.00% 0.00%   0.00%       0.00%   0.00%   0.00%       0.00%   0.00%   0.00%                
Amortization deferred financing costs                               1,532,228     547,210                                     260,022     28,719                
Deferred financing costs 260,022                                                                          1,451,934                      
Number of shares purchased forfeit             833,000                                                                                    
Valuation method of warrants               Black-Scholes Model                                                                                  
Non-cash compensation recongised               405,066     77,034         360,528 218,045             15   7,158 36,284 36,284                                          
Prepaid expense-short term                     154,068       360,528 360,528                                                                  
Prepaid expense-long term                     308,128       593,127 593,127                                                                  
Prepaid expense                                             323 323                                                  
Fair value of warrants by relative fair value calculation method                                   1,649,890                                                              
Remaining amortization deferred financing costs                                     1,102,680                                                            
Debt discount                                                                             859,647                    
Number of unaffiliated individuals                           5               3                                                      
Professional fees                           29,736               1,656                                                      
Description of vesting period of warrants                                                 The Warrants vest over a 44-month period beginning on November 21, 2011 (or 13,636 shares for months 1-43 and 13,652 shares for month 44).             Warrants vested at the rate of an aggregate of 76,714 shares per calendar quarter end.                                  
Agreement covering period                                             3 months                                                    
Financing expense                                                           25,980                                      
Amortization research and development expense                                                             12,548                                    
Research and development expense 13,551,263 4,492,362 107,241                                                           0 6,936 5,612                            
Note payable                                                                                 500,000                
Minimum volatility rate                                                                                 39.13%                
Maximum volatility rate                                                                                 39.15%                
Minimum risk free rate                                                                                 1.38%                
Maximum risk free rate                                                                                 1.65%                
Line of credit       179,000 179,000 179,000                                                   300,000       100,000           299,220 300,000 100,000 100,000 100,000      
Warrants issued                                                               613,713                                  
Number of warrants vested                                                                 562,571                                
Loan guaranty costs $ 2,944 $ 45,036 $ 38,159                                                           $ 2,944 $ 45,036 $ 38,159